TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15211599

Group type: EXPERIMENTAL
Intervention: CDDP+CPT‐11 (CPT‐P) arm
Number of subjects: 100

Group type: COMPARATOR
Intervention: CDDP+VDS (VDS‐P) arm
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CPT‐P arm
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CPT‐P arm with identical second-line radiotherapy
Number of subjects: 100
Study: 11145793

Group type: EXPERIMENTAL
Intervention: 0.03% tacrolimus ointment
Number of subjects: 632

Group type: EXPERIMENTAL
Intervention: 0.1% tacrolimus ointment
Number of subjects: 632

Group type: COMPARATOR
Intervention: vehicle
Number of subjects: 632
Study: 9848045

Group type: EXPERIMENTAL
Intervention: Acticoat silver-coated dressing
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.5% silver nitrate solution
Number of subjects: 30
Study: 7924731

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg twice daily)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 2769353

Group type: EXPERIMENTAL
Intervention: Unilateral backward perturbations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unilateral forward perturbations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bilateral perturbations in one direction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bilateral perturbations in opposite directions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unilateral displacement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bilateral displacements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gastrocnemius muscle activation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tibialis anterior muscle activation
Number of subjects: 0
Study: 402186

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HPO)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Air (control)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Extended fields (HPO)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Lymphadenectomy (HPO)
Number of subjects: 233
Study: 31222789

Group type: EXPERIMENTAL
Intervention: Standardized electronic messages four times/week for 6 months postpartum
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standardized electronic messages with option for nurse contact for 6 months postpartum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 0
Study: 29150046

Group type: EXPERIMENTAL
Intervention: Preterm infants
Number of subjects: 50
Study: 26063693

Group type: EXPERIMENTAL
Intervention: DASH diet with pork (DASH-P)
Number of subjects: 19

Group type: COMPARATOR
Intervention: DASH diet with chicken and fish (DASH-CF)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both DASH-P and DASH-CF
Number of subjects: 19
Study: 23443788

Group type: EXPERIMENTAL
Intervention: Low-intensity ultrasound treatment for 30 min daily for 3 consecutive days
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (no particular treatments)
Number of subjects: 122
Study: 22411387

Group type: EXPERIMENTAL
Intervention: Oral powder supplement enriched with eicosapentaenoic acid (1.5 g)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Standard liquid supplement
Number of subjects: 61
Study: 19540010

Group type: EXPERIMENTAL
Intervention: Universal helmet laws
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mandatory rider education programs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Speed limits on rural interstates
Number of subjects: 0
Study: 16953857

Group type: EXPERIMENTAL
Intervention: Home Visiting Group (HVG) - received eight home visits with education and support for parenting, breastfeeding, and child development.
Number of subjects: 152

Group type: COMPARATOR
Intervention: Control Group (CG) - received telephone contact at two months and a home visit at six months, no education or support provided.
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Both groups (HVG and CG)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Retention rates
Number of subjects: 152
Study: 15208597

Group type: EXPERIMENTAL
Intervention: Amb a 1 linked to immunostimulatory DNA sequence (AIC)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 11258638

Group type: EXPERIMENTAL
Intervention: Running at 90% of vVO2max
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Running at 100% of vVO2max
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Running at 120% of vVO2max
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Running at 140% of vVO2max
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Velocity expressed as %MSR for tlim90 and tlim100
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Velocity expressed as %AnSR for tlim120 and tlim140
Number of subjects: 10
Study: 9143748

Group type: EXPERIMENTAL
Intervention: Exercise treatment (90 min/day of isotonic and isokinetic lower extremity exercise training)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 18
Study: 7960017

Group type: EXPERIMENTAL
Intervention: Increased cardiac index
Number of subjects: 2677

Group type: EXPERIMENTAL
Intervention: End-systolic wall stress
Number of subjects: 2677

Group type: EXPERIMENTAL
Intervention: Increased heart rate in men
Number of subjects: 2677
Study: 3550148

Group type: COMPARATOR
Intervention: Cisplatin alone
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Cisplatin, doxorubicin and cyclophosphamide
Number of subjects: 87
Study: 31478704

Group type: EXPERIMENTAL
Intervention: Hurricane scenario (negative)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Minor storm scenario (neutral)
Number of subjects: 48
Study: 29144993

Group type: EXPERIMENTAL
Intervention: Valproate (VPA)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Lamotrigine (LTG)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Substitution of VPA with LTG
Number of subjects: 66
Study: 27566116

Group type: EXPERIMENTAL
Intervention: Early Childhood Mental Health Consultation (ECMHC) through Connecticut's statewide Early Childhood Consultation Partnership (ECCP)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Waitlist control treatment
Number of subjects: 176
Study: 24515352

Group type: EXPERIMENTAL
Intervention: CEPO (carbamylated EPO) 325 µg thrice-weekly
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 23063681

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTA) 300 U
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTA) 100 U
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTA) 500 U
Number of subjects: 60
Study: 20647284

Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccine (3 doses at day 1, month 2, and month 6)
Number of subjects: 17622
Study: 18580409

Group type: EXPERIMENTAL
Intervention: Progressive strength training (ST, n = 72)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Standard care (CO, n = 76)
Number of subjects: 148
Study: 16809804

Group type: EXPERIMENTAL
Intervention: 4 g P‐OM3
Number of subjects: 24

Group type: COMPARATOR
Intervention: 80 mg simvastatin
Number of subjects: 24
Study: 14653037

Group type: EXPERIMENTAL
Intervention: Laparoscopic totally extraperitoneal technique
Number of subjects: 123

Group type: COMPARATOR
Intervention: Lichtenstein open tension free mesh technique
Number of subjects: 123
Study: 10825519

Group type: EXPERIMENTAL
Intervention: Posterior cervical foraminotomy (FOR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anterior cervical discectomy with fusion (ACDF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anterior cervical discectomy without fusion (ACD)
Number of subjects: 0
Study: 8964410

Group type: EXPERIMENTAL
Intervention: Prednisolone (group I)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Prednisolone (group III)
Number of subjects: 183

Group type: COMPARATOR
Intervention: No treatment (group II)
Number of subjects: 183

Group type: COMPARATOR
Intervention: No treatment (group IV)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Treated patients with marked liver polymorphonuclear infiltrate
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Treated patients without marked liver polymorphonuclear infiltrate
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Treated patients with polymorphonuclear counts > 5500/mm3
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Treated patients with polymorphonuclear counts ≤ 5500/mm3
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Liver polymorphonuclear infiltrate
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Polymorphonuclear count
Number of subjects: 183
Study: 1381822

Group type: EXPERIMENTAL
Intervention: Mexiletine (M)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Other antiarrhythmic drugs
Number of subjects: 82
Study: 3856903

Group type: EXPERIMENTAL
Intervention: Vaginal film formulation containing 850 micrograms PGE2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo vaginal film
Number of subjects: 0
Study: 29278753

Group type: EXPERIMENTAL
Intervention: LRYGB with Intraoperative Endoscopy (IOE)
Number of subjects: 100

Group type: COMPARATOR
Intervention: LRYGB without Intraoperative Endoscopy (Control)
Number of subjects: 100
Study: 26938918

Group type: EXPERIMENTAL
Intervention: SnMP (4.5 mg kg ‐1)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 213
Study: 24015968

Group type: EXPERIMENTAL
Intervention: Enhanced physical education programme including cognitively demanding (open skill) activities
Number of subjects: 70

Group type: COMPARATOR
Intervention: Curricular physical education only
Number of subjects: 70
Study: 22386222

Group type: EXPERIMENTAL
Intervention: Multidimensional infection control approach implemented during phase 2.
Number of subjects: 16429

Group type: COMPARATOR
Intervention: Baseline VAP rate during phase 1 (before intervention).
Number of subjects: 16429
Study: 20633511

Group type: EXPERIMENTAL
Intervention: Pharmacopuncture using root bark of Ulmus davidiana Planch (UDP), administered twice a week for 6 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline injections
Number of subjects: 60
Study: 18349490

Group type: EXPERIMENTAL
Intervention: FABQ physical activity scale (cut-off >14)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: FABQ work scale (cut-off >29)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Manipulation and exercise
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: FABQ physical activity scale
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: FABQ work scale
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: FABQ work scale (cut-off scores)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Overall sample
Number of subjects: 160
Study: 18959111

Group type: EXPERIMENTAL
Intervention: Video assisted thoracoscopic anterior correction
Number of subjects: 49

Group type: COMPARATOR
Intervention: Small incision, thoracotomic anterior correction
Number of subjects: 49
Study: 15033843

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) with state of the art equipment and standardized growth training session
Number of subjects: 878

Group type: COMPARATOR
Intervention: Control Group (CG) without intervention
Number of subjects: 878

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG)
Number of subjects: 878

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 878
Study: 11388882

Group type: EXPERIMENTAL
Intervention: Lorazepam 0.038 mg/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 9253566

Group type: EXPERIMENTAL
Intervention: 50% inspired oxygen
Number of subjects: 43

Group type: COMPARATOR
Intervention: 25% inspired oxygen
Number of subjects: 43
Study: 8276047

Group type: EXPERIMENTAL
Intervention: Flunitrazepam (1 mg) administered once daily for 8 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo administered once daily for 8 days
Number of subjects: 0
Study: 3821824

Group type: EXPERIMENTAL
Intervention: 10 mM cysteamine eyedrops
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control (untreated eye)
Number of subjects: 2
Study: 31727910

Group type: EXPERIMENTAL
Intervention: Alanine transaminase (ALT)
Number of subjects: 3458

Group type: EXPERIMENTAL
Intervention: Alkaline phosphatase (ALP)
Number of subjects: 3458

Group type: EXPERIMENTAL
Intervention: Mendelian randomization (MR) for ALT
Number of subjects: 3458

Group type: EXPERIMENTAL
Intervention: Mendelian randomization (MR) for ALP and GGT
Number of subjects: 3458
Study: 28877165

Group type: EXPERIMENTAL
Intervention: Unsupervised water exercise twice a week for 12 weeks
Number of subjects: 516

Group type: COMPARATOR
Intervention: Standard prenatal care
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Unsupervised water exercise
Number of subjects: 516
Study: 25543679

Group type: EXPERIMENTAL
Intervention: Full-mouth ultrasonic subgingival debridement followed by Er:YAG laser application
Number of subjects: 40

Group type: COMPARATOR
Intervention: Two sessions of ultrasonic debridement
Number of subjects: 40
Study: 22819247

Group type: EXPERIMENTAL
Intervention: Mixed mode stimulation (alternating cathodic and anodic)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Continuous anodic stimulation (full power)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Stimulation duration
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Electrode location in lateral and anterior regions of DLPFC
Number of subjects: 11
Study: 21889063

Group type: EXPERIMENTAL
Intervention: Conventional appliance
Number of subjects: 50

Group type: COMPARATOR
Intervention: Self-ligating appliance
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Crowding
Number of subjects: 50
Study: 20193310

Group type: EXPERIMENTAL
Intervention: CTN‐Vero‐RV
Number of subjects: 450

Group type: COMPARATOR
Intervention: PVRV
Number of subjects: 450
Study: 16462549

Group type: EXPERIMENTAL
Intervention: Manual-based treatment for schizophrenia
Number of subjects: 0
Study: 15201492

Group type: EXPERIMENTAL
Intervention: Kanji words reading
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Kana words reading
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Kana nonword reading
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Pure alexia (ventromedial type)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Pure alexia (posterior type)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Alexia with agraphia (orthographic alexia with agraphia)
Number of subjects: 3
Study: 10903538

Group type: EXPERIMENTAL
Intervention: Consultations with different mental health professionals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In-patient days
Number of subjects: 0
Study: 9291201

Group type: EXPERIMENTAL
Intervention: Candoxatrilat (100 mg i.v. bolus)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 7687206

Group type: EXPERIMENTAL
Intervention: Thyroxine (150-200 micrograms daily for 3 months)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2942494

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 2 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Lorazepam 2.5 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Midazolam 30 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 2 mg (after three repeated doses)
Number of subjects: 9
Study: 30341124

Group type: EXPERIMENTAL
Intervention: Combined physical and psychological intervention (BOOST programme)
Number of subjects: 402

Group type: COMPARATOR
Intervention: Best practice advice (control)
Number of subjects: 402
Study: 27411009

Group type: EXPERIMENTAL
Intervention: Vancomycin
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Antibiotics (Vancomycin and Amoxicillin)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 24720927

Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 2331
Study: 23168750

Group type: EXPERIMENTAL
Intervention: Day 1 discharge
Number of subjects: 360

Group type: COMPARATOR
Intervention: Day 2 discharge
Number of subjects: 360
Study: 20350945

Group type: EXPERIMENTAL
Intervention: MGAWN1 (0.3, 1, 3, 10, or 30 mg/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: MGAWN1 (3 mg/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: MGAWN1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: MGAWN1 (30 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 40
Study: 18034842

Group type: EXPERIMENTAL
Intervention: Vildagliptin (100 mg daily, given as equally divided doses)
Number of subjects: 576

Group type: COMPARATOR
Intervention: Pioglitazone (30 mg daily, given as a single q.d. dose)
Number of subjects: 576
Study: 16210717

Group type: EXPERIMENTAL
Intervention: Multivitamins (B complex, C, and E)
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Vitamin A plus beta-carotene
Number of subjects: 1078

Group type: EXPERIMENTAL
Intervention: Multivitamins that included vitamin A plus beta-carotene
Number of subjects: 1078

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1078
Study: 11440493

Group type: EXPERIMENTAL
Intervention: Dipyridamole alone at a dose of 75 mg t.i.d. orally for 8 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dipyridamole with exercise training at 60% of peak VO2 three times a week for 8 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no dipyridamole or exercise training)
Number of subjects: 30
Study: 9699428

Group type: EXPERIMENTAL
Intervention: Posterior resin-bonded bridges (PRBBs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Replacement PRBBs
Number of subjects: 0
Study: 7761963

Group type: EXPERIMENTAL
Intervention: Taleum (sodium cromoglycate) inhalation aerosol
Number of subjects: 34

Group type: COMPARATOR
Intervention: Intal powder inhaled with the aid of a spinhaler
Number of subjects: 34
Study: 3143016

Group type: EXPERIMENTAL
Intervention: Thiotepa
Number of subjects: 149

Group type: COMPARATOR
Intervention: Mitomycin C
Number of subjects: 149
Study: 29371479

Group type: EXPERIMENTAL
Intervention: Daratumumab monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daratumumab in combination with lenalidomide and dexamethasone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daratumumab in combination with bortezomib and dexamethasone
Number of subjects: 0
Study: 27265987

Group type: EXPERIMENTAL
Intervention: In-water recompression (IWR) for 82 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normobaric oxygen (NBO2) for 82 minutes
Number of subjects: 0
Study: 24243397

Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program (4 weeks of walking, balance and cognitive exercises, followed by 4 weeks of resistance exercise performed twice weekly at 20-50% of 1RM)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: After 24 weeks of training cessation
Number of subjects: 18
Study: 22537508

Group type: EXPERIMENTAL
Intervention: Hatha yoga therapy
Number of subjects: 250

Group type: COMPARATOR
Intervention: Therapeutic exercises
Number of subjects: 250
Study: 20027105

Group type: EXPERIMENTAL
Intervention: 60 mg rolofylline administered by intravenous infusion over 2 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral moxifloxacin
Number of subjects: 0
Study: 18605129

Group type: EXPERIMENTAL
Intervention: Therapeutic relationship measures (working alliance, interpersonal behavior, narrative coherency) in early sessions
Number of subjects: 48
Study: 15964408

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil 3 g daily (n = 22)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Mycophenolate mofetil 2 g daily (n = 94)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil 3 g daily (n = 21)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Mycophenolate mofetil 2 g daily (n = 29)
Number of subjects: 166
Study: 11728846

Group type: EXPERIMENTAL
Intervention: Maintenance medication
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Prodrome-based intervention
Number of subjects: 363

Group type: COMPARATOR
Intervention: Crisis intervention
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Intermittent treatment
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Prodrome-based intermittent intervention
Number of subjects: 363
Study: 10802777

Group type: EXPERIMENTAL
Intervention: linomide (roquinimex)
Number of subjects: 811
Study: 8625684

Group type: EXPERIMENTAL
Intervention: MV+PEEP, hypervolemia
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: MV+PEEP, normovolemia
Number of subjects: 21

Group type: COMPARATOR
Intervention: Spontaneous breathing (SB), hypervolemia
Number of subjects: 21
Study: 1471839

Group type: EXPERIMENTAL
Intervention: Continuous passive motion (CPM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (immobilisation regimen)
Number of subjects: 0
Study: 6368874

Group type: EXPERIMENTAL
Intervention: Desaminocysteine‐D‐arginine vasopressin (20 micrograms intranasally)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 54
Study: 30827470

Group type: EXPERIMENTAL
Intervention: IMT alongside comprehensive chest PT (PT+IMT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Comprehensive chest PT (PT)
Number of subjects: 36
Study: 29589086

Group type: COMPARATOR
Intervention: Subchondral bone marrow concentrate injection (average of 6500 MSCs/mL)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 30
Study: 27117455

Group type: EXPERIMENTAL
Intervention: Ultrathin bronchoscopy (UB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard-size bronchoscopy (SB)
Number of subjects: 40
Study: 24630419

Group type: EXPERIMENTAL
Intervention: Alvimopan 12 mg (maximum: 15 inpatient doses)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 277
Study: 22906179

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention with low-intensity psychological treatments delivered by IAPT services.
Number of subjects: 450

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention.
Number of subjects: 450